Novartis Investigative Site

Waco, Texas 76712

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Atherosclerosis, Chronic Obstructive Pulmonary Disease, Hypocalcemia, Leukaemia, Lymphocytic, Chronic, Lymphoma, Non-Hodgkin, Paget's Disease of the Bone, Rheumatoid Arthritis

Studies at this site

• Dose Finding Study for QAW039 in Asthma — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia — Stopped early
• Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) — Completed
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) — Completed
• Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast® — Completed
• NVA237 Versus Placebo 12-week Efficacy Study — Completed